TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Amy Comstock Rick, J.D.


President and Chief Executive Officer, Food and Drug Law Institute 


Amy Comstock Rick, J.D., is the President and Chief Executive Officer of the Food and Drug Law Institute (FDLI), a nonprofit organization that provides education, training, and publications, and promotes discussion of food and drug law issues to inform public policy and regulation. Prior to joining FDLI, Ms. Rick was the Chief Executive Officer of the Parkinson’s Action Network (PAN), a Washington D.C.-based national nonprofit focused on educating the public and government leaders on better policies for research and therapy development and an improved quality of life for people living with Parkinson’s disease. Ms. Rick has also served as the President of the Coalition for the Advancement of Medical Research, on the Boards of Directors of Research!America, the National Health Council, and the American Brain Coalition. Before joining PAN, she was the Senate-confirmed Director of the U.S. Office of Government Ethics from 2000-2003 and the Associate Counsel to the President in the White House Counsel’s Office from 1998-2000. Ms. Rick began her federal service as a career attorney at the U.S. Department of Education in 1989 and became the Assistant General Counsel for Ethics in 1993. Prior to her government service, Ms. Rick was an associate attorney at the law firm of Beveridge & Diamond. She received a Bachelor of Arts degree from Bard College and a Juris Doctor degree from the University of Michigan. She previously served on the Scientific Liaison Group for the NINDS Parkinson’s Disease Biomarkers Program, as well as the NINDS Morris K. Udall Centers of Excellence for Parkinson’s Disease Research Coordinating Committee.  Ms. Rick has testified before Congress and is a national spokesperson for Parkinson’s disease policy issues and stem cell research.


Last Modified June 8, 2015